Clinical Trial Update: Laboratory-Treated Autologous Lymphocytes and Aldesleukin After Cyclophosphamide and Fludarabine in Treating Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating laboratory-treated autologous lymphocytes with Aldesleukin after cyclophosphamide and fludarabine in metastatic melanoma; the study w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Aldesleukin (interleukin-2)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)
• Laboratory-treated autologous lymphocytes

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Melanoma (Skin) | Phase 2 | Status: TERMINATED | Results posted: 2014-12-17